Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study (Q35688369)
Jump to navigation
Jump to search
scientific article published on 30 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study |
scientific article published on 30 December 2011 |
Statements
1 reference
Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study (English)
1 reference
Markolf Hanefeld
1 reference
Robert M Cuddihy
1 reference
David Russell-Jones
1 reference
Ajay Kumar
1 reference
Jose G González
1 reference
Melanie Chan
1 reference
Anne M Wolka
1 reference
Marilyn K Boardman
1 reference
DURATION-4 Study Group
1 reference
30 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference